BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 577180)

  • 1. [Problems of dose finding: sexual hormones (author's transl)].
    Neumann F; Elger W; Nishino Y; Steinbeck H
    Arzneimittelforschung; 1977 Feb; 27(2A):296-318. PubMed ID: 577180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of pharmaceutical compounds on male fertility.
    Neumann F; Diallo FA; Hasan SH; Schenck B; Traore I
    Andrologia; 1976; 8(3):203-35. PubMed ID: 793446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Preclinical research and development of norethisterone].
    Mcguire JL; Hahn DW; Philipps A
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):437-44. PubMed ID: 12280212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Influence of anabolic agents on behavior].
    Signoret JP
    Environ Qual Saf Suppl; 1976; (5):143-50. PubMed ID: 1066274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
    Cianci A; De Leo V
    Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological and endocrinological studies on anabolic agents.
    Neumann F
    Environ Qual Saf Suppl; 1976; (5):253-64. PubMed ID: 782871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effectiveness of anabolic agents in increasing rate of growth in farm animals; report on experiments in cattle.
    Heitzman RJ
    Environ Qual Saf Suppl; 1976; (5):89-98. PubMed ID: 782875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Thirty years after the appearance of the first oral contraceptive, clinical and biological analysis of a new estrogen-progestin combination, a three phase pill containing gestodene].
    Belaisch J; Hommais-loufrani B
    Fertil Contracept Sex; 1988 Apr; 16(4 Suppl):1-8. PubMed ID: 12342078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocrinological studies with desogestrel.
    van der Vies J; de Visser J
    Arzneimittelforschung; 1983; 33(2):231-6. PubMed ID: 6221730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogens in oral contraceptives: historical perspectives.
    Goldzieher JW
    Johns Hopkins Med J; 1982 May; 150(5):165-9. PubMed ID: 7043034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The present state of research on the relationship of oral contraceptives to breast cancer].
    Pike MC
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):329-38. PubMed ID: 12280203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relevance of the pharmacologic properties of a progestational agent to its clinical effects as a combination oral contraceptive.
    Upton GV; Corbin A
    Yale J Biol Med; 1989; 62(5):445-57. PubMed ID: 2534253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rationale for prescribing oral contraceptives].
    Teichmann AT
    Wien Med Wochenschr; 1998; 148(7):171-4. PubMed ID: 9700865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of various combined oral contraceptives on sex steroids, gonadotropins and SHBG.
    Mall-Haefeli M; Werner-Zodrow I; Huber PR; Darragh A; Lambe R
    Ir Med J; 1983 Jun; 76(6):266-7, 269-72. PubMed ID: 6683715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Final amended report on the safety assessment of Methylparaben, Ethylparaben, Propylparaben, Isopropylparaben, Butylparaben, Isobutylparaben, and Benzylparaben as used in cosmetic products.
    Int J Toxicol; 2008; 27 Suppl 4():1-82. PubMed ID: 19101832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacological aspects of oral contraceptives (author's transl)].
    Weil-levy C; Soubrie C; Simon P
    Contracept Fertil Sex (Paris); 1980 Feb; 8(2):123-7. PubMed ID: 12336185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormonal properties of norethisterone, 7alpha-methyl-norethisterone and their derivatives.
    Schoonen WG; Deckers GH; de Gooijer ME; de Ries R; Kloosterboer HJ
    J Steroid Biochem Mol Biol; 2000 Nov; 74(4):213-22. PubMed ID: 11162927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation and noncontraceptive uses of the new, low-dose oral contraceptive.
    Batzer FR
    J Reprod Med; 1984 Jul; 29(7 Suppl):503-12. PubMed ID: 6237195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors associated with the use of sex hormones.
    Taylor W
    Anticancer Res; 1987; 7(5B):943-8. PubMed ID: 2829703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The benefit of the classification of oral contraceptives. Studies of 525 women taking oral contraceptives (author's transl)].
    Wenderlein JM
    MMW Munch Med Wochenschr; 1981 Jun; 123(23):957-61. PubMed ID: 6789156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.